Pharmafile Logo

Medscape Education Wins SILVER for Rare Disease Campaign

July 24, 2025 | Silver Award, rare disease 

- PMLiVE

We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education Information division category by the 2025 National Health Information Awards! This recognition highlights the powerful impact of our campaign, “Shortening the Journey for Patients with a Rare Disease,” and affirms our commitment to advancing healthcare education.

Every day, over 300 million people around the world live with a rare disease, many waiting years for a diagnosis. In February 2024, we launched Shorten the Journey, a month-long digital initiative culminating on Rare Disease Day (February 29). The campaign combined compelling patient stories, precision-targeted outreach, and free, accredited education to empower clinicians to recognize and diagnose rare conditions faster.

And the results* were extraordinary:

  • 462% increase in traffic to our Pathways in Rare Disease learning center 
  • 53% boost in engagement with our rare disease education  
  • Over 46,000 unique learners engaged in rare disease education, with 60% reached through social media 

Since its launch in 2021, Pathways in Rare Disease has engaged 1.5 million healthcare professionals, with patient voices at the core of every activity.. We are proud of the momentum we have built, and our ongoing commitment to improving rare disease diagnosis and care. 

Looking ahead, we are accelerating our impact: expanding global access, leveraging new technologies, and fostering partnerships to further shorten the diagnostic journey for millions worldwide.

*Source: Medscape Internal Use Data. Feb 2024

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Education and M4RD: Together Caring for Rare Disease

We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...

The Need for and Impact of Rare Disease Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

ESMO’s New Focus on Cancer Prevention

During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...